Literature DB >> 17052219

Structure and trafficking of NMDA and GABAA receptors.

F A Stephenson1.   

Abstract

The fidelity of synaptic function is dependent on the expression of the appropriate neurotransmitter receptor subtype, the targeting and trafficking of receptors to synapses as well as the regulation of the actual number of receptors at synapses. GABAA (gamma-aminobutyric acid type A) receptors and NMDA (N-methyl-D-aspartate) receptors are both examples of ligand-gated, heteromeric neurotransmitter receptors whose cell-surface expression is dynamic and tightly regulated. NMDA receptors are localized at excitatory synapses. These synapses are highly structured but dynamic, with the interplay between NMDA receptors and NMDA receptor-associated scaffolding proteins regulating the expression of functional cell-surface synaptic and extrasynaptic receptors. Based on current information, inhibitory synapses seem to be less ordered, and a GABAA receptor equivalent of PSD-95 (postsynaptic density-95), the scaffolding molecule pivotal to the organization of NMDA receptor complexes at synapses, is yet to be validated. In the present paper, processes regulating the trafficking, assembly and molecular organization of both NMDA receptors and GABAA receptors will be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052219     DOI: 10.1042/BST0340877

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  19 in total

1.  Acute hypoxia differentially affects the NMDA receptor NR1, NR2A and NR2B subunit mRNA levels in the developing chick optic tectum: stage-dependent plasticity in the 2B-2A ratio.

Authors:  Marina Vacotto; Melina Rapacioli; Vladimir Flores; Sara Fiszer de Plazas
Journal:  Neurochem Res       Date:  2010-07-02       Impact factor: 3.996

2.  A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission.

Authors:  Laura M Saba; Beth Bennett; Paula L Hoffman; Kelsey Barcomb; Takao Ishii; Katerina Kechris; Boris Tabakoff
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

Review 3.  Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology.

Authors:  Vladimir Parpura; Elizabeth S Fisher; James D Lechleiter; Arne Schousboe; Helle S Waagepetersen; Sylvain Brunet; Selva Baltan; Alexei Verkhratsky
Journal:  Neurochem Res       Date:  2016-02-25       Impact factor: 3.996

4.  Metabolomic differences in heart failure patients with and without major depression.

Authors:  David C Steffens; K Ranga R Krishnan; Edward D Karoly; Matthew W Mitchell; Christopher M O'Connor; Rima Kaddurah-Daouk
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-01-25       Impact factor: 2.680

Review 5.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

6.  MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

Authors:  Joseph O'Neill; John C Piacentini; Susanna Chang; Jennifer G Levitt; Michelle Rozenman; Lindsey Bergman; Noriko Salamon; Jeffry R Alger; James T McCracken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-10-01       Impact factor: 5.067

7.  Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia.

Authors:  Min-Chih Cheng; Chao-Lin Lu; Sy-Ueng Luu; Ho-Min Tsai; Shih-Hsin Hsu; Tzu-Ting Chen; Chia-Hsiang Chen
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

Review 8.  Glutamate and anxiety disorders.

Authors:  Jonathan M Amiel; Sanjay J Mathew
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  Association analysis of genetic variant of rs13331 in PSD95 gene with autism spectrum disorders: A case-control study in a Chinese population.

Authors:  Jia Wang; Li Li; Shan-Shan Shao; Zhen He; Yan-Lin Chen; Rui Kong; Xiao-Hui Zhang; Jian-Hua Gong; Ran-Ran Song
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.